NIRMAI

Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates. We, at NIRAMAI, have developed a novel artificial intelligence-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated in any clinic. Our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution has been developed using our patented machine learning algorithms for reliable and accurate detection of breast cancer. This unique solution can be used as a cancer diagnosis test in hospitals, for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas. Niramai Thermalytix is available in 30 cities in India across 200+ Hospitals and Diagnostic Centers. Our customers include Apollo Clinics, HCG, Narayana Health, Rainbow Hospitals among others. Niramai test is also available in United Arab Emirates, Kenya, Sweden, Turkey, and Philippines through our distributors.